A carregar...

Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer

SIMPLE SUMMARY: About one third of all breast cancers are classified as HER2-positive due to high levels of the HER2 cell surface protein. Drugs that target HER2 have been mostly successful, but this type of cancer returns at a high frequency once treatment has been completed. The high levels of HER...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Holloway, Ryan W., Marignani, Paola A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230691/
https://ncbi.nlm.nih.gov/pubmed/34208071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122922
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!